Napier Park Global Capital (Us) LP Bristol Myers Squibb CO Call Options Transaction History

Napier Park Global Capital (Us) LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $13.4 Million - $14.8 Million	-300,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $13.5 Million - $16.1 Million	300,000 New	300,000 $20,000
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $5.31 Million - $6.61 Million	-105,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $6.29 Million - $7.24 Million	105,000 New	105,000 $39,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Napier Park Global Capital (Us) LP, based on Form 13F filings with the SEC.

Stay updated on Napier Park Global Capital (Us) LP with notifications on news.